Andrew Sneddon
Independent Director
Innate Immunotherapeutics
New Zealand
Biography
Andrew is a former partner of PricewaterhouseCoopers (PWC). In his PWC role, Andrew led the Life Sciences Practise and specialised in fast growth and emerging technology companies working with many companies from start-up to successful global corporations. Andrew has extensive experience in a wide range of technical areas including mergers and acquisitions, business and strategic planning, audit, valuation, capital raising and stock exchange listings on the Australian, NASDAQ and London Stock Exchanges. He has worked across a broad range of industries and is currently a non executive director at ClearView Wealth Limited and the chairman of Elastagen Pty Ltd and TGR BioSciences Pty Ltd. He is also a member of the Audit and Compliance Committees of the Crescent Capital Private Equity Funds.
Research Interest
Research interest on Pharamcotherapeutics
